Literature DB >> 23234378

Application of the information, motivation and behavioural skills model for targeting HIV risk behaviour amongst adolescent learners in South Africa.

Misheck Ndebele1, Mambwe Kasese-Hara, Michael Greyling.   

Abstract

This paper discusses the application of an information, motivation and behavioural skills (IMB) model in a school-based programme for the reduction of HIV risk behaviour among 259 Grade 11 learners in two high schools in Alexandra township, Johannesburg. School 1 was the Experimental group, while School 2 was the Control group. After a baseline study (Time 1) at both schools, a 3-week intervention programme was conducted at School 1. A post-test (Time 2) was conducted at both schools. The intervention was repeated at School 2, followed by another post-test (Time 3) at both schools. A final test (Time 4) was conducted at both schools. While there were positive changes in the levels of HIV&AIDS IMB in learner participants, these changes may not be entirely attributed to the intervention. If an IMB model-based intervention is to be maximally effective in reducing HIV-risk behaviour among adolescents, it must focus on the behavioural, structural and socio-cultural contexts in which adolescents live.

Entities:  

Mesh:

Year:  2012        PMID: 23234378     DOI: 10.1080/17290376.2012.744903

Source DB:  PubMed          Journal:  SAHARA J        ISSN: 1729-0376


  2 in total

Review 1.  The effect of HIV educational interventions on HIV-related knowledge, condom use, and HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Lena Faust; Sanni Yaya
Journal:  BMC Public Health       Date:  2018-11-13       Impact factor: 3.295

2.  A Smartphone Game-Based Intervention (Tumaini) to Prevent HIV Among Young Africans: Pilot Randomized Controlled Trial.

Authors:  Kate Winskell; Gaëlle Sabben; Victor Akelo; Ken Ondeng'e; Christopher Obong'o; Rob Stephenson; David Warhol; Victor Mudhune
Journal:  JMIR Mhealth Uhealth       Date:  2018-08-01       Impact factor: 4.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.